Dimensional Fund Advisors
HRTX icon

Dimensional Fund Advisors’s Heron Therapeutics HRTX Stock Holding History

Dimensional Fund Advisors’s Portfolio HRTX Stock Details HRTX Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2022
Q2 		– Sell
-318,705
Closed -$1.82M – 3496
2022
Q1 		$1.82M Sell
318,705
-18,176
-5% -$133K ﹤0.01% 2854
2021
Q4 		$3.08M Buy
336,881
+19,682
+6% +$201K ﹤0.01% 2725
2021
Q3 		$3.39M Sell
317,199
-311,146
-50% -$3.79M ﹤0.01% 2687
2021
Q2 		$9.75M Buy
628,345
+15,161
+2% +$241K ﹤0.01% 2368
2021
Q1 		$9.94M Buy
613,184
+87,292
+17% +$1.56M ﹤0.01% 2327
2020
Q4 		$11.1M Sell
525,892
-12,017
-2% -$209K ﹤0.01% 2236
2020
Q3 		$7.97M Buy
537,909
+107,283
+25% +$1.67M ﹤0.01% 2298
2020
Q2 		$6.33M Buy
430,626
+170,391
+65% +$2.8M ﹤0.01% 2388
2020
Q1 		$3.06M Buy
260,235
+35,247
+16% +$663K ﹤0.01% 2578
2019
Q4 		$5.29M Hold
224,988
– – ﹤0.01% 2590
2019
Q3 		$4.16M Buy
224,988
+110,892
+97% +$2.04M ﹤0.01% 2656
2019
Q2 		$2.12M Buy
+114,096
New +$2.28M ﹤0.01% 2886
2019
Q1 		– Sell
-17,338
Closed -$450K – 3453
2018
Q4 		$450K Buy
+17,338
New +$477K ﹤0.01% 3162
2015
Q1 		– Sell
-580
Closed -$6K – 3362
2014
Q4 		$6K Hold
580
– – ﹤0.01% 3472
2014
Q3 		$5K Hold
580
– – ﹤0.01% 3508
2014
Q2 		$7K Hold
580
– – ﹤0.01% 3551
2014
Q1 		$8K Buy
+580
New +$7.75K ﹤0.01% 3554

Other funds holding HRTX

State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
Franklin Resources
Franklin Resources San Mateo, California $408B AUM 30.18% 1-Year Est. Return
UOC
UBS O'Connor Chicago, Illinois $3.38B AUM 63.08% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
BBA
Baker Bros. Advisors New York $17.4B AUM 131.5% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
JP Morgan Chase
JP Morgan Chase New York $1.56T AUM 27.86% 1-Year Est. Return
ACH
ArrowMark Colorado Holdings Denver, Colorado $3.76B AUM 21.77% 1-Year Est. Return
TCM
Tang Capital Management San Diego, California $1.97B AUM 125.1% 1-Year Est. Return
SCM
Suvretta Capital Management New York $3.92B AUM 86.67% 1-Year Est. Return

Dimensional Fund Advisors's HRTX Position: Q2 2022 in Review

Dimensional Fund Advisors sold out of Heron Therapeutics (HRTX) in Q2 2022, closing a stake of 318,705 shares — an estimated $1.82M sold.

Dimensional Fund Advisors first reported a position in HRTX in Q1 2014 and held it in 17 quarters. The position peaked at $11.1M in Q4 2020. 174 funds tracked by Wall St. Rank hold HRTX as of Q2 2022.

  • Dimensional Fund Advisors reported no remaining Heron Therapeutics position as of Q2 2022 after selling out during the quarter.
  • Dimensional Fund Advisors sold 318,705 Heron Therapeutics shares in Q2 2022, an estimated $1.82M.
  • Dimensional Fund Advisors first reported a position in Heron Therapeutics in Q1 2014 and held it in 17 quarters.
  • Dimensional Fund Advisors's Heron Therapeutics position peaked at $11.1M in Q4 2020.
  • 174 funds tracked by Wall St. Rank held Heron Therapeutics as of Q2 2022.

Based on Dimensional Fund Advisors's 13F filing for Q2 2022, filed 12 Aug 2022.